Patents by Inventor Michael D. Lynch

Michael D. Lynch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9078638
    Abstract: A device and method for aspirating fluid from a body cavity are disclosed herein. The device disclosed utilizes a reservoir in fluid communication with a needle via a tube connected to a pump. The needle is able to displace a desired distance. Further, the aspirator includes a selector switch capable having three positions. In the first position anticoagulant is pumped through the system. In the second position bone marrow is aspirated but the needle is not moved. In the third position the displacement of the needle is controlled as well as the volume in the reservoir. Further, in the third position, the volume in the reservoir and the needle displacement are proportional to one another.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: July 14, 2015
    Assignee: Howmedica Osteonics Corp.
    Inventors: Thies Wuestemann, Michael D. Lynch, Carlos E. Collazo
  • Publication number: 20150119601
    Abstract: The present invention provides various combinations of genetic modifications to a transformed host cell that provide increase conversion of carbon to a chemical product. The present invention also provides methods of fermentation and methods of making various chemical products.
    Type: Application
    Filed: March 17, 2014
    Publication date: April 30, 2015
    Applicant: OPX Biotechnologies, Inc.
    Inventors: Hans LIAO, Christopher Patrick MERCOGLIANO, Travis Robert WOLTER, Michael Tai Man LOUIE, Wendy Kathleen RIBBLE, Tanya LIPSCOMB, Eileen Colie SPINDLER, Michael D LYNCH
  • Publication number: 20150072399
    Abstract: The present invention relates to methods, systems and compositions, including genetically modified microorganisms, directed to achieve decreased microbial conversion of 3-hydroxypropionic acid (3-HP) to aldehydes of 3-HP. In various embodiments this is achieved by disruption of particular aldehyde dehydrogenase genes, including multiple gene deletions. Among the specific nucleic acids that are deleted whereby the desired decreased conversion is achieved are aldA, aldB, puuC), and usg of E. coli. Genetically modified microorganisms so modified are adapted to produce 3-HP, such as by approaches described herein.
    Type: Application
    Filed: May 12, 2014
    Publication date: March 12, 2015
    Applicant: OPX Biotechnologies, Inc.
    Inventors: Michael D. Lynch, Christopher P. Mercogliano, Matthew L. Lipscomb, Tanya E. W. Lipscomb
  • Publication number: 20150072384
    Abstract: Microorganism compositions are described that comprise combinations of genetic modifications that include a genetic modification to increase oxaloacetate alpha-decarboxylase enzymatic activity. By such genetic modification a 3-hydroxypropionic acid (“3-HP”) production pathway is provided or improved.
    Type: Application
    Filed: July 25, 2014
    Publication date: March 12, 2015
    Inventors: Michael D. Lynch, Christopher P. Mercogliano
  • Publication number: 20150064754
    Abstract: The present invention provides various combinations of genetic modifications to a transformed host cell that provide increase conversion of carbon to a chemical product. The present invention also provides methods of fermentation and methods of making various chemical products.
    Type: Application
    Filed: March 17, 2014
    Publication date: March 5, 2015
    Inventors: Hans LIAO, Christopher Patrick MERCOGLIANO, Travis Robert WOLTER, Michael Tai Man LOUIE, Wendy Kathleen RIBBLE, Tanya LIPSCOMB, Eileen Colie SPINDLER, Michael D LYNCH
  • Publication number: 20150057465
    Abstract: The present invention provides various combinations of genetic modifications to a transformed host cell that provide increase conversion of carbon to a chemical product. The present invention also provides methods of fermentation and methods of making various chemical products.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 26, 2015
    Inventors: Hans LIAO, Christopher Patrick MERCOGLIANO, Travis Robert WOLTER, Michael Tai Man LOUIE, Wendy Kathleen RIBBLE, Tanya LIPSCOMB, Eileen Colie SPINDLER, Michael D. LYNCH
  • Publication number: 20150056684
    Abstract: The present invention relates to methods, systems and compositions, including genetically modified microorganisms, adapted to exhibit increased tolerance to 3-hydroxypropionic acid (3-HP), particularly through alterations to interrelated metabolic pathways identified herein as the 3-HP toleragenic pathway complex (“3HPTGC”). In various embodiments these organisms are genetically modified so that an increased 3-HP tolerance is achieved. Also, genetic modifications may be made to provide at least one genetic modification to any of one or more 3-HP biosynthesis pathways in microorganisms comprising one or more genetic modifications of the 3HPTGC.
    Type: Application
    Filed: February 12, 2014
    Publication date: February 26, 2015
    Applicants: The Regents of the University of Colorado, OPX Biotechnologies, Inc.
    Inventors: TANYA E. W. LIPSCOMB, MICHAEL D. LYNCH, RYAN T. GILL
  • Publication number: 20150056669
    Abstract: The present invention provides various combinations of genetic modifications to a transformed host cell that provide increase conversion of carbon to a chemical product. The present invention also provides methods of fermentation and methods of making various chemical products.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 26, 2015
    Inventors: Hans LIAO, Christopher Patrick MERCOGLIANO, Travis Robert WOLTER, Michael Tai Man LOUIE, Wendy Kathleen RIBBLE, Tanya LIPSCOMB, Eileen Colie SPINDLER, Michael D LYNCH
  • Publication number: 20150056651
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes polyketides and 3-hydroxypropionic acid.
    Type: Application
    Filed: April 7, 2014
    Publication date: February 26, 2015
    Inventors: Michael D. Lynch, Ryan T. Gill, Tanya E.W. Lipscomb
  • Publication number: 20150031100
    Abstract: Embodiments of the present invention concerns methods and compositions for the construction of a series of vectors containing a chemical sensing module to assess the production of a chemical compound by a microorganism.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 29, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Ryan T. Gill, Michael D. Lynch, Tirzah Y. Mills
  • Patent number: 8883464
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.
    Type: Grant
    Filed: September 27, 2010
    Date of Patent: November 11, 2014
    Assignees: OPX Biotechnologies, Inc., The Regents of the University of Colorado, a Body Corporate
    Inventors: Michael D. Lynch, Ryan T. Gill, Tanya E. W. Lipscomb
  • Publication number: 20140330032
    Abstract: Metabolically engineered microorganism strains are disclosed, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product. Such chemical products include polyketides, 3-hydroxypropionic acid, and various other chemical products described herein. Methods of production also may be applied to further downstream products, such as consumer products. In various embodiments, modifications to a microorganism and/or culture system divert, at least transiently, usage of malonyl-coA from the fatty acid biosynthesis pathway and thereby provides for usage of the malonyl-coA for a chemical product other than a fatty acid. In various embodiments, the fatty acid biosynthesis pathway is modulated to produce specific fatty acids or combinations of fatty acids.
    Type: Application
    Filed: March 22, 2012
    Publication date: November 6, 2014
    Inventors: Michael D. Lynch, Tanya E.W. Lipscomb, Ashley D, Trahan, Amarjeet Singh, Travis Wolter
  • Patent number: 8809027
    Abstract: Microorganism compositions are described that comprise combinations of genetic modifications that include a genetic modification to increase oxaloacetate alpha-decarboxylase enzymatic activity. By such genetic modification a 3-hydroxypropionic acid (“3-HP”) production pathway is provided or improved. In various embodiments, comprising other genetic modifications, including selected gene disruptions, 3-HP production is greater than in a control microorganism lacking such combinations of genetic modifications.
    Type: Grant
    Filed: September 27, 2010
    Date of Patent: August 19, 2014
    Assignee: OPX Biotechnologies, Inc.
    Inventors: Michael D Lynch, Christopher P. Mercogliano
  • Publication number: 20140170731
    Abstract: Embodiments herein generally relate to methods, compositions, systems and uses for enabling bio-production of or increasing bio-production of alcohol molecules by microorganisms. Certain embodiments relate to compositions and methods enabling or increasing the bio-production of 4-carbon alcohol molecules by bacteria. In some embodiments, compositions and methods relate to introducing isobutyryl-CoA isomerase to a culture of microorganisms to enable or increase the bio-production of four-carbon alcohols. Variations of biosynthesis pathways for microbial bio-production of butanol and/or isobutanol are provided.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 19, 2014
    Applicant: OPX BIOTECHNOLOGIES, INC.
    Inventor: Michael D. Lynch
  • Publication number: 20140135526
    Abstract: Methods of obtaining mutant nucleic acid sequences that demonstrate elevated oxaloacetate a-decarboxylase activity are provided. Compositions, such as genetically modified microorganisms that comprise such mutant nucleic acid sequences, are described, as are methods to obtain the same.
    Type: Application
    Filed: October 30, 2013
    Publication date: May 15, 2014
    Applicant: OPX Biotechnologies, Inc.
    Inventor: Michael D. Lynch
  • Publication number: 20140120595
    Abstract: Three biosynthetic pathways are disclosed for microorganism bio-production of 1,4-Butanediol from various carbon sources. Exemplary methods are provided. The recombinant microorganisms comprising any of these 1,4-Butanediol biosynthesis pathways may also comprise genetic modifications directed to improved tolerance for 1,4-Butanediol.
    Type: Application
    Filed: September 27, 2013
    Publication date: May 1, 2014
    Applicant: OPX BIOTECHNOLOGIES, INC.
    Inventor: MICHAEL D. LYNCH
  • Publication number: 20140051136
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism
    Type: Application
    Filed: August 9, 2013
    Publication date: February 20, 2014
    Applicant: OPX Biotechnologies, Inc.
    Inventors: Hans Liao, Eileen Spindler, Joseph R. Warner, Michael Louie, Wendy Ribble, Brittany Prather, Ron Evans, Tanya E.W. Lipscomb, Michael D. Lynch
  • Patent number: 8652816
    Abstract: Methods of obtaining mutant nucleic acid sequences that demonstrate elevated oxaloacetate ?-decarboxylase activity are provided. Compositions, such as genetically modified microorganisms that comprise such mutant nucleic acid sequences, are described, as are methods to obtain the same.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: February 18, 2014
    Assignee: OPX Biotechnologies, Inc.
    Inventor: Michael D. Lynch
  • Publication number: 20140045231
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.
    Type: Application
    Filed: June 12, 2013
    Publication date: February 13, 2014
    Applicants: THE REGENTS OF THE UNIVERSITY OF COLORADO, OPX BIOTECHNOLOGIES, INC.
    Inventors: Michael D. LYNCH, Ryan T. GILL, Tanya E.W. LIPSCOMB
  • Patent number: 8528920
    Abstract: An adjustment assembly includes first and second connection points associated with a component. The second connection point is selectively adjustable to adjust a position of the component. A shield has one end coupled to the first connection point and an opposite end proximate to the second connection point to selectively prevent access to the second connection point. The shield is selectively movable when the first connection point is loosened to allow access to the second connection point. To achieve proper adjustment of the component, the first connection point must be loosened prior to adjusting a position of the second connection point.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: September 10, 2013
    Assignee: Arvinmeritor Technology, LLC
    Inventors: Gustavo Vieira Borges, Robert J. Brazeau, Christopher J. Wittry, Michael D. Lynch, Michael A. Power, Gregory Todd Smith, Kenneth G. Lang, Anthony E. Nicol, Gregory D. Pavuk, Edward J. Gebal, Thomas S. Mijal, Esequiel Berra de Mello, Christopher S. Keeney, David G. Gonska